A diagnostic ‘cocktail,’ containing a single drop of blood, a dribble of water and a dose of DNA powder with gold particles, could one day lead to the treatment of the world’s leading diseases.
This homegrown brew is being developed by IBBME PhD student Kyryl Zagorovsky and Professor Warren Chan (IBBME), a Canada Research Chair in Nanobiotechnology, and a recent winner of the NSERC E.W.R. Steacie Memorial Fellowship.
“There’s been a lot of emphasis in developing simple diagnostics,” said Professor Chan. “The question is, how do you make it simple enough, portable enough?”
Professor Chan’s lab studies nanoparticles – in particular, the use of gold particles in sizes so small that they are measured in the nanoscale. He and his group are working on custom-designing nanoparticles to target and illuminate cancer cells and tumours, with the potential of one day being able to deliver drugs to cancer cells.
Zagorovsky’s rapid-diagnostic biosensor will allow technicians to test for multiple diseases at one time with one small sample, and with high accuracy and sensitivity. The biosensor relies upon gold particles in much the same vein as your average pregnancy test. With a pregnancy test, gold particles turn the test window red because the particles are linked with an antigen that detects a certain hormone in the urine of a pregnant woman.
“Gold is the best medium,” explained Professor Chan, “because it’s easy to see. It emits a very intense colour.”
Currently, scientists can target a particular disease by linking gold particles with DNA strands. When a sample containing the disease gene (e.g., Malaria) is present, it clumps the gold particles, turning the sample blue.
Rather than clumping the particles together, Zagorovsky immerses the gold particles in a DNA-based enzyme solution (DNA-zyme) that, when the disease gene is introduced, ‘snip’ the DNA from the gold particles, turning the sample red.
“It’s like a pair of scissors,” said Zagorovsky. “The target gene activates the scissors that cut the DNA links holding gold particles together.”
The advantage is that far less of the gene needs to be present for the solution to show noticeable colour changes, amplifying detection. A single DNA-zyme can clip up to 600 ‘links’ between the target genes.
Just a single drop from a biological sample such as saliva or blood can potentially be tested in parallel, so that multiple diseases can be tested in one sitting.
The Latest Bing News on:
Rapid-diagnostic biosensor
- Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Resultson April 18, 2024 at 8:23 am
Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...
- Quantum computing, AI, and semiconductor innovationson April 18, 2024 at 8:02 am
In the dynamic landscape of technology, quantum computing and artificial intelligence (AI) emerge as transformative forces, poised to revolutionize industries and reshape investment paradigms.
- Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Resultson April 18, 2024 at 5:31 am
Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024, with highest quarterly cartridge sales since 2022 Intelligent ...
- Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL"on April 17, 2024 at 5:00 pm
VIP guests, including biotech leaders from across government, academia, business, and research, were introduced to a number of "born global" biotech residents working on health issues across ...
- UPDATE: Abbott Diagnostics Q1 Revenues Down 18 Percent, Total Revenues up 2 Percenton April 17, 2024 at 10:18 am
The firm's Q1 diagnostics revenues fell on a declining COVID-19 testing business as COVID-19 test sales dropped to $204 million from $730 million.
- Point of Care Diagnostics Market Latest Trends, Size, Key Players, Revenue, Growth, and Forecast to 2024 to 2032on April 16, 2024 at 5:55 pm
Report Ocean recently published a research report titled “Point of Care Diagnostics Market” 2024 Forecast to 2032 Analysis by Market Trends.” This study delivers accurate economic projections, ...
- Global Point-of-Care Diagnostics Market Poised for Exponential Growth, Reaching US$ 74.8 Billion by 2033on April 15, 2024 at 8:45 pm
Point-of-Care Diagnostics Market is anticipated to soar to US$ 74.8 billion by 2033 witness a remarkable expansion at a CAGR of 6.8%.
- Global Cytocentrifuge Market Poised for Exponential Growth, Reaching $2.1 Billion by 2033on April 14, 2024 at 8:35 pm
Cytocentrifuge Market is set to witness remarkable growth to an estimated value of US$ 2.1 billion by 2033, Fueled by a CAGR of 4.5%.
- FDA gives nod to Affinity Biosensors’ flagship producton April 12, 2024 at 10:03 pm
Affinity Biosensors, a Santa Barbara-based healthcare diagnostics company, announced April 3 that its flagship LifeScale AST system has received FDA clearance. The company said that the FDA’s approval ...
- University startup gets distribution deal for sepsis AI diagnostic toolon April 11, 2024 at 7:45 am
A biotech company with local roots has landed a distribution deal for its AI tool for sepsis diagnosis, with the news coming just one week after the technology received authorization from the Food and ...
The Latest Google Headlines on:
Rapid-diagnostic biosensor
[google_news title=”” keyword=”rapid-diagnostic biosensor” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
[/vc_column_text]
The Latest Bing News on:
Multiple disease testing
- CDC: Deer meat didn't cause hunters' deaths; concerns about chronic wasting disease remainon April 26, 2024 at 1:26 pm
There have been no cases of chronic wasting disease in people to date, the CDC says. But it is still investigating the potential risks.
- Blood test may be able to detect osteoarthritis 8 years earlier than X-rayon April 26, 2024 at 12:00 pm
A blood test could help predict knee osteoarthritis at least eight years before the signs of the disease show up on X-rays, a new study indicates.
- What It’s Like to Live With Neurologic Lyme Disease: A Patient Perspectiveon April 26, 2024 at 6:24 am
Diagnosing patients with neurologic Lyme disease can take upwards of 2 years, which Maria Arini Lopez discovered first-hand in the spring of 2021.
- Start Mass Testing Dairy Workers for Bird Fluon April 26, 2024 at 6:00 am
Given how devastating another global pandemic would be, the US should start mass testing of dairy workers for the bird flu virus that’s spreading fast through cows. If necessary, either the Centers ...
- This Biotech Startup Aims To Speed Up Drug Testing On Animalson April 26, 2024 at 3:29 am
Gordian Biotechnology’s platform allows for potentially hundreds of gene therapies to be tested in an animal at the same time — without harming it.
- Phase 2 trial testing dazucorilant in ALS patients now fully enrolledon April 24, 2024 at 5:05 am
A Phase 2 clinical trial testing Corcept's cortisol modulator dazucorilant in adults with sporadic or familial ALS is now fully enrolled.
- Labcorp, Quest add new blood tests for Alzheimer's, brain tissue damageon April 22, 2024 at 11:16 am
The twin clinical testing giants Labcorp and Quest Diagnostics have each, in the past week, added to their portfolios new blood tests that aim to peek into the workings of the human brain.
- New skin test to detect patients with Parkinson's Diseaseon April 21, 2024 at 8:08 am
A new skin test could detect Parkinson's Disease earlier than it can currently be diagnosed. Ashley Michels has the story.
- Blood test may identify who is at risk for developing multiple sclerosison April 19, 2024 at 7:49 am
An early marker of multiple sclerosis could help doctors figure out who will eventually fall prey to the degenerative nerve disease, a new study says.
- Signs of multiple sclerosis can be detected in blood 5 years before symptoms appear, new study finds. Here's why this breakthrough is important.on April 19, 2024 at 2:00 am
What you need to know about the study, as well as who is most at risk for multiple sclerosis and early signs to look out for.
The Latest Google Headlines on:
Multiple disease testing
[google_news title=”” keyword=”multiple disease testing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]